Insight

May 18, 2024, 12:07

Amer Zeidan: Another great project led by super star Maximilian Stahl

Amer Zeidan shared a post on X:

“Another great project led by super star Maximilian Stahl with collaborations between Dana-Farber Cancer Institute, Yale Cancer Center, Memorial Sloan Kettering Cancer Center, Rory M. Shallis, Jan Bewersdorf, Shai Shimony, and others on sequential therapy for IDH mutated AMLsm, American Journal Hematology.”

Additional information.
Source: Amer Zeidan/X

Amer Zeidan is an Associate Professor of Medicine (Hematology) at Yale University. He is also the medical director of Hematology Early Therapeutics Research, the leader of the Myeloid Malignancies DART (Disease Aligned Research Team), and the director of Continuing Medical Education (CME) at the Hematology division and chairs the Protocol Review Committee (PRC) at Yale Cancer Center. Dr. Zeidan is a well-known leukemia researcher with a special focus on targeted therapies and immunotherapy for myeloid malignancies, and a social media influencer in the field of blood cancer.

Aaron Goldberg Amer M. Zeidan Amer Zeidan American Journal Hematology Anthony Stein Brian Ball cancer Dana-Farber Cancer Institute Daniel J. DeAngelo Donna S. Neuberg Eva J. Schaefer Evan C. Chen Eytan Stein Guido Marcucci Guillaume Berton Ibrahim Aldoss Jan Philipp Bewersdorf Jorge Ramos Maximilian Stahl Memorial Sloan Kettering Cancer Center OncoDaily Oncology R. Coleman Lindsley Rebecca P. Bystrom Richard M. Stone Rory M. Shallis Shai Shimony Sylvain Garciaz Vinod Pullarkat Yale Cancer Center Yale University Yiwen Liu

Sharon Osbourne and Colon Cancer: How She Went Against, How She Survived, and More

Marcia Cross and Anal Cancer: How She Went Against, How She Survived, and More

Pancreatic Cancer: Symptoms, Causes, Types, Diagnosis & Treatment

Former Disney CEO Bob Chapek Appointed Senior Adviser at SCAN Group

FDA approves Methotrexate for Pediatric acute Lymphoblastic Leukemia

Special Coverage